Invention Grant
- Patent Title: Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposure
-
Application No.: US14974930Application Date: 2015-12-18
-
Publication No.: US10537568B2Publication Date: 2020-01-21
- Inventor: Bruce Chandler May
- Applicant: Inflammatory Response Research, Inc.
- Applicant Address: US CA Santa Barbara
- Assignee: IRR, Inc.
- Current Assignee: IRR, Inc.
- Current Assignee Address: US CA Santa Barbara
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/47 ; A61K31/56 ; A61K45/06
Abstract:
The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
Public/Granted literature
- US20160175301A1 USE OF LEVOCETIRIZINE AND MONTELUKAST TO AMELIORATE INFLAMMATION FOLLOWING RADIATION EXPOSURE Public/Granted day:2016-06-23
Information query
